17 research outputs found
Oxaliplatin As Part of Adjuvant Therapy for Colon Cancer: More Complicated Than Once Thought
No full textCommentary: Practice Patterns and Potential Impact on Quality Measures for a Practicing Physician
No full textAdjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment
No full text
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
No full textAdjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
No full textValidation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin
No full text
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand
No full textDoublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis
No full text
